Anika Therapeutics (ANIK) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $22.03 --0%
Financial Fact:
Research & development: 2.82M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research & development: 2.82M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of ($0.12), $0.11 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $37.85 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
- Euroseas Ltd. (ESEA) Tops Q2 EPS by 61c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
